What is Evaxion?
Evaxion operates at the vanguard of the biotechnology industry, utilizing a sophisticated AI-Immunology platform to decode complex immune system signatures. By identifying and designing personalized vaccines for oncology and infectious diseases, the company addresses critical gaps in current medical treatments. Their multidisciplinary approach allows for the rapid identification of therapeutically relevant targets, effectively shortening the timeline from discovery to clinical application. As a TechBio entity, Evaxion distinguishes itself by integrating computational biology with clinical research, positioning itself as a high-growth player in the global healthcare innovation landscape.
How much funding has Evaxion raised?
Evaxion has raised a total of $40M across 1 funding round:
Private Equity
$40M
Private Equity (2022): $40M with participation from Lincoln Park Capital
Key Investors in Evaxion
Lincoln Park Capital
Lincoln Park Capital is a Chicago-based investment group and asset management firm that specializes in opportunistic investing across public and private companies, real estate, and various money management strategies.
What's next for Evaxion?
With this recent capital injection, Evaxion is well-positioned to accelerate its clinical pipeline and expand its research capabilities. The strategic focus will likely shift toward optimizing its AI-driven discovery engine and scaling its manufacturing partnerships to support late-stage development. Investors are closely monitoring the company's ability to translate its computational insights into tangible patient outcomes, which remains the primary catalyst for long-term value creation. As the firm matures, the integration of its vaccine candidates into broader clinical frameworks will be essential for maintaining its competitive edge in the global biotech market. Keywords: TechBio, AI-Immunology, Personalized Vaccines, Biotechnology, Clinical Development, Strategic Investment, Healthcare Innovation, Precision Medicine.
See full Evaxion company page
